Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with governmental entities in Europe in their respective investigations on the company’s Vioxx product.
Investigations are…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that As of September 30, 2009, the Company had been served or was aware that it had been named…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that as of June 30, 2009, the Company had been served or was aware that it had been named…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the motion for rehearing en banc regarding the Texas state court case, Ernst v. Merck, was due on…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is responding to the subpoena sent by the State of California Attorney General in connection with company’s…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with U.S. Attorney s Office for the District of Massachusetts.
In March 2009, Merck received a…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that in the MDL proceeding of the Vioxx dispute, the parties and the court have agreed that the Louisiana…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with governmental entities in Europe in their respective investigations on the company’s Vioxx product.
Investigations are…
Merck & Co. Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with the U.S. Department of Justice regarding a probe centered on its Vioxx product activities.
The…
Medtronic Inc. will comply as required with the terms of the administrative subpoena issued by New Jersey Attorney General, Division of Consumer Affairs on June 16, 2009, the company disclosed in its company’s latest annual report on Form 10-K filed…